Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells

被引:184
作者
Fehérvári, Z
Sakaguchi, S
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan
[2] RIKEN, Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan
[3] Japan Sci & Technol Agcy, CREST Program, Kawaguchi 3320012, Japan
基金
日本学术振兴会;
关键词
anergy; CD25+CD4+T-R; DC; LPS; regulation;
D O I
10.1093/intimm/dxh178
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naturally occurring CD4(+)CD25(+) regulatory T (T-R) cells play crucial roles in normal immunohomeostasis. CD4(+)CD25(+) T-R cells exhibit a number of interesting in vitro properties including a 'default state' of profound anergy refractory to conventional T cell stimuli. We investigated the in vitro activation requirements of CD4(+)CD25(+) T-R cells using bone marrow-derived DC, which as professional antigen presenting cells (APC) can support the activation of normal naive T cells. Comparison of different APC types revealed that LPS-matured DC were by far the most effective at breaking CD4(+)CD25(+) T-R cell anergy and triggering proliferation, and importantly their IL-2 production. Examination of Foxp3, a key control gene for CD4(+)CD25(+) T-R cells, showed this to be stably expressed even during active proliferation. Although CD4(+)CD25(+) T-R cell proliferation was equivalent to that of CD25(-) cells their IL-2 production was considerably less. Use of IL-2(-/-) mice demonstrated that the DC stimulatory ability was not dependent on IL-2 production; nor did IL-15 appear crucial but was, at least in part, related to costimulation. DC also blocked normal CD4(+)CD25(+) T-R cell-mediated suppression partially via IL-6 secretion. DC therefore possess novel mechanisms to control the suppressive ability, expansion and/or differentiation of CD4(+)CD25(+) T-R cells in vivo.
引用
收藏
页码:1769 / 1780
页数:12
相关论文
共 36 条
[1]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[2]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[3]   Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[4]  
Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
[5]  
2-X
[6]   Modulation of tryptophan catabolism by regulatory T cells [J].
Fallarino, F ;
Grohmann, U ;
Hwang, KW ;
Orabona, C ;
Vacca, C ;
Bianchi, R ;
Belladonna, ML ;
Fioretti, MC ;
Alegre, ML ;
Puccetti, P .
NATURE IMMUNOLOGY, 2003, 4 (12) :1206-1212
[7]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[8]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[9]   Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo [J].
Gavin, MA ;
Clarke, SR ;
Negrou, E ;
Gallegos, A ;
Rudensky, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :33-41
[10]   New embo member's review - Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity [J].
Granucci, F ;
Zanoni, I ;
Feau, S ;
Ricciardi-Castagnoli, P .
EMBO JOURNAL, 2003, 22 (11) :2546-2551